MBX Biosciences, Inc. Common Stock
MBX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $49,351 | $30,523 | $24,210 |
| Short-Term Investments | $212,798 | $50,153 | $18,251 |
| Receivables | $682 | $208 | $142 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $4,455 | $2,581 | $1,608 |
| Total Curr. Assets | $267,286 | $83,465 | $44,211 |
| Property Plant & Equip (Net) | $1,199 | $665 | $842 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $50 | $50 | $42 |
| Total NC Assets | $1,249 | $715 | $884 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $268,535 | $84,180 | $45,095 |
| Liabilities | – | – | – |
| Payables | $5,335 | $1,391 | $976 |
| Short-Term Debt | $171 | $153 | $137 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $5,545 | $2,382 | $2,318 |
| Total Curr. Liab. | $11,051 | $3,926 | $3,431 |
| LT Debt | $0 | $171 | $324 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $42 | $152,551 | $83,945 |
| Total NC Liab. | $42 | $152,722 | $84,269 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $171 | $324 | $461 |
| Total Liabilities | $11,093 | $156,648 | $87,700 |
| Equity | – | – | – |
| Pref Stock | $0 | $0 | $0 |
| Common Stock | $5 | $1 | $1 |
| Retained Earnings | -$137,505 | -$75,583 | -$43,020 |
| AOCI | $55 | $60 | $3 |
| Other Equity | $394,887 | $3,054 | $411 |
| Total Equity | $257,442 | -$72,468 | -$42,605 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $268,535 | $84,180 | $45,095 |
| Net Debt | -$49,180 | -$30,199 | -$23,749 |